Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02627066 · ClinicalTrials.gov registry record · NA
Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT02627066 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 37 participants.
The verdict
NCT02627066, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
This is a 12 month randomized clinical trial in which patients with renal failure undergoing maintenance hemodialysis (MHD) therapy will be placed on a volume reduction protocol that includes a novel low sodium dietary education program mediated by a lifestyle interventionist with significant collaboration from the existing clinic staff. Participating patients will be randomized to receive: 1) the volume control protocol alone (VC), or 2) the volume control protocol + physical activity and exercise counseling (VCE) from the lifestyle interventionist (LI). A research dietitian (RD), working in collaboration with the existing clinic RD, will develop a program to immerse clinics in a culture of sodium restriction. The research RD will train the LI and other clinic staff (nurses, technicians, etc) to help disseminate this program, modeled after the clinic-wide dissemination approach used in Izmir, Turkey (Dr. Ercan Ok). In addition, the LI will provide exercise and physical activity counseling to the participants randomized to the exercise group, utilizing a SCT-based approach. The Investigators hypothesize that mean arterial pressure will be reduced, and physical function increased, in all patients at 12 months, but the magnitude of these improvements will be greater in the VCE group.
Interventions
- BEHAVIORAL Volume Control
- BEHAVIORAL Volume Control + Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02627066
The ClinicalTrials.gov registry entry for NCT02627066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Volume Control is the first listed.
NCT02627066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02627066 about?
NCT02627066 is a clinical study titled "Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise". This is a 12 month randomized clinical trial in which patients with renal failure undergoing maintenance hemodialysis (MHD) therapy will be placed on a volume reduction protocol that includes a novel low sodium dietary education program mediated by a lifestyle interventionist with significant collab...
What is the current status of trial NCT02627066?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2015-12. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02627066?
The interventions under investigation include: Volume Control (BEHAVIORAL), Volume Control + Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02627066?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.